跳至主要内容
临床试验/NCT03535714
NCT03535714Unknown不适用

MANTR-a: Evaluation of a Therapeutic Intervention for Adolescents and Young Adults With Anorexia Nervosa

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年4月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Improvement of eating disorder symptomatology based on professional's rating

研究概览

简要总结

The aim of this study is to test effectiveness of a new treatment program for adolescents and young adults within the age of 14-21 suffering from AN (MANTR-a) compared to treatment as usual (TAU).

详细描述

Anorexia nervosa (AN) is a serious mental illness which leads untreated to aggravation of symptomatology and chronification. Among all mental illnesses, AN has the highest mortality rate, which is about 5.1 per 1000 people per year. High drop-out rates (up to 40%) or small treatment motivation constrains treatment success. Since the onset of AN is mainly in adolescence, it is important to start with therapy as early as possible and establish an effective single-setting treatment program for this age group to prevent chronification.

MANTR-a (Maudsley model of anorexia nervosa treatment for adolescents) is an innovative, theory-based, tailored treatment program which combines a cognitive behavioural approach with motivational interviewing. The main focus of the treatment program is the transformation maintaining factors of AN, like personality aspects, pro-anorexic beliefs, emotion regulation strategies, thinking styles and obstructive behaviour from caregivers.

The aim of this study is the examination ot the effectiveness of the MANTR-a treatment program for adolescents and young adults. Therefore we compare MANTR-a (intervention group) with treatment as usual (control group). Assessments will be conducted before treatment (T0, baseline), after six months (T1), after 12 months (T2) and after 18 months (T3, follow-up) via questionnaires, interviews and neuropsychological measurements. Process evaluation takes place after every session. Each group consists of female adolescents and young adults within the age of 14-21 suffering from AN (ICD-10: F50.0, F50.1), resulting in an overall sample size of 100.

The long-term goal of the study is to provide an evidence-based outpatient treatment for children and adolescents with AN in order to prevent a chronic course of the disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
14 Years 至 21 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • ICD-10 diagnosis of anorexia nervosa (F50.0) or atypical anorexia nervosa (F50.1).

排除标准

  • life-threatening AN requiring immediate inpatient treatment as defined by NICE (2017)
  • insufficient cognitive ability
  • insufficient knowledge of German language to understand the treatment
  • severe mental or physical illness that needs treatment on its own (e.g. psychosis)
  • substance abuse
  • pregnancy

结局指标

主要结局

Improvement of eating disorder symptomatology based on professional's rating

时间窗: 12 months

Professionals use a structured clinical interview ("Eating Disorder Examination - EDE") to rate severity of eating disorder symptomatology

Increase of BMI

时间窗: 12 months

Weight and height will be assessed and combined to report BMI in kg/m\^2

Improvement of eating disorder symptomatology based on patient's self-rating

时间窗: 12 months

"Eating Disorder Inventory-2 (EDI-2)" is used to assess eating disorder symptomatology from a patients's view

次要结局

  • Increase of BMI(6 months, 18 months)
  • Improvement of eating disorder symptomatology based on patient's self-rating(6 months, 18 months)
  • Group differences: improvement of eating disorder symptomatology based on patient's self-rating(6 months, 12 months, 18 months)
  • Reduction of depression(6 months, 12 months, 18 months)
  • Quality of life (group differences, improvement over time)(6 months, 12 months, 18 months)
  • Improvement of comorbid symptomatology based on professional's rating(6 months, 12 months, 18 months)
  • Increase of central coherence(12 months)
  • Increase of emotion recognition(12 months)
  • Influence of motivation of change(12 months)
  • Influence of treatment contentment(6 months, 12 months)
  • Improvement of eating disorder symptomatology based on professional's rating(6 months, 18 months)
  • Reduction of obsessive-compulsive symptomatology(6 months, 12 months, 18 months)
  • Group differences: improvement of eating disorder symptomatology based on professional's rating(6 months, 12 months, 18 months)
  • Group differences: increase of BMI(6 months, 12 months, 18 months)
  • Reduction of anxiety(6 months, 12 months, 18 months)
  • Increase of cognitive flexibility(12 months)
  • Influence of therapeutic relationship(6 months, 12 months)
  • Changes in personality(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Andreas Karwautz

Univ. Prof. Dr.

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验

Maudsley Model of Anorexia Nervosa Treatment for... | 临床试验